SCHEMBL3377435

SCHEMBL3377435

CC(C)(C)OC(=O)CC(=O)CS

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
DGAT1 O75907 1/20 0.37
CYP2D6 P10635 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
CA2 P00918 2/20 0.34
CA12 O43570 2/20 0.34
CA14 Q9ULX7 2/20 0.34
TDP1 Q9NUW8 1/20 0.33
EPHX2 P34913 1/20 0.33
CA1 P00915 2/20 0.32
CA7 P43166 2/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648388 0.85 DGAT1 (0.42) TSHRDGAT1CYP2D6HDAC3HDAC1
SCHEMBL10833684 0.84 TDP1 (0.38) TSHRHSD17B10DGAT1CYP2D6HDAC3
SCHEMBL1186918 0.80
SCHEMBL241533 0.80 DGAT1 (0.46) TSHRDGAT1CYP2D6HDAC3HDAC1
SCHEMBL182237 0.79 TDP1 (0.41) DGAT1CYP2D6HDAC3HDAC1HDAC2
Bromide SCHEMBL8558052 0.78 TSHR (0.48) TSHRHSD17B10DGAT1CYP2D6HDAC3
Methyl Alcohol SCHEMBL27995686 0.78 DGAT1 (0.44) TSHRDGAT1CYP2D6HDAC3HDAC1
SCHEMBL25275143 0.77 DGAT1 (0.37) TSHRDGAT1CYP2D6HDAC3HDAC1
SCHEMBL5691337 0.77 GAA (0.42) DGAT1CYP2D6HDAC3HDAC1HDAC2
SCHEMBL7107983 0.77 FAAH (0.44) DGAT1CYP2D6CA2CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010040989-A1 QUINOLIN-2-ONE COMPOUNDS ARGENTA ORAL THERAPEUTICS LIMITED (GB) 2010-04-15 WO disclosed
US-4616084-A Process for the preparation of 7-acylamino-3-hydroxy-cephem-4-carboxylic acids and 7-acylamino-3-hydroxy-1-dethia-1-oxacephem-4-carboxylic acids BAYER AKTIENGESELLSCHAFT (DE) 1986-10-07 US disclosed